- Home
- / Human Stem Cells Institute
Human Stem Cells Institute
Revenue
₽1.7 B
FY, 2025
Human Stem Cells Institute Summary
Company Summary
- Overview
- Human Stem Cells Institute is a biomedical technologies and healthcare solutions provider. It develops and implements medicines, neovasculgen, gemabank, reprobank, genetico, prenetix, oncogenetics, bioinformatics, therapies, genetic diagnosis and counseling.
- Type
- Public
- Status
- Active
- Founded
- 2003
- HQ
- Moscow, RU | view all locations
- Website
- https://hsci.ru/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Moscow HQ
Russian Federation
Human Stem Cells Institute Financials
Summary Financials
- Revenue (FY, 2025)
- ₽1.7B
- Gross profit (FY, 2025)
- ₽1.4B
- Net income (FY, 2025)
- ₽107.7M
- Cash (FY, 2025)
- ₽565.4M
- EBIT (FY, 2025)
- ₽106.6M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026